Cancer conferences. Can they be improved?
P D Guinan1, J P Imperato, J S Chmiel
1Department of Urology, University of Illinois College of Medicine, Chicago 60612, USA.
Cancer Practice
|October 28, 1997
Summary
Cancer conferences adequately discuss clinical details but often omit TNM staging, tumor markers, and quality of life. Improving these discussions can enhance patient care and hospital accreditation.
Area of Science:
- Oncology
- Healthcare Management
Background:
- Cancer conferences are crucial for hospital accreditation by the American College of Surgeons.
- These conferences offer vital educational and clinical opportunities, influencing cancer patient management.
- They represent a significant investment of time and resources for healthcare professionals.
Purpose of the Study:
- To evaluate the clinical aspects discussed during hospital cancer conferences.
- To identify areas for improvement in the content of cancer conference presentations.
Main Methods:
- A questionnaire was distributed to 93 Illinois hospitals regarding case presentations at six cancer conferences.
- The survey collected data on presenters, clinical information, pathology (including TNM staging), therapeutic options, and quality-of-life issues.
Main Results:
- Clinical history, physical examination, and diagnostic tests were discussed in over 90% of the 1547 reviewed cases.
- TNM staging, tumor markers, and quality-of-life issues were discussed in only 28%, 34%, and 38% of presentations, respectively.
- Attending physicians and multidisciplinary team members were frequent presenters.
Conclusions:
- While clinical characteristics are well-documented, essential parameters like TNM staging, tumor markers, and quality of life are underrepresented.
- Enhancing the discussion of these specific elements in cancer conferences can significantly improve patient care.
- Addressing these gaps is crucial for optimizing the value of cancer conferences.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...